KAS
GILD icon

Kestra Advisory Services’s Gilead Sciences GILD Stock Holding History

Kestra Advisory Services’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13M Buy
102,648
+4,587
+5% +$604K 0.04% 438
2026
Q1 		$13.7M Buy
98,061
+2,907
+3% +$407K 0.05% 371
2025
Q4 		$11.7M Buy
95,154
+36,524
+62% +$4.44M 0.05% 377
2025
Q3 		$6.51M Buy
58,630
+3,083
+6% +$350K 0.03% 552
2025
Q2 		$6.16M Sell
55,547
-19,504
-26% -$2.08M 0.03% 545
2025
Q1 		$8.41M Sell
75,051
-11,583
-13% -$1.2M 0.04% 399
2024
Q4 		$8M Buy
86,634
+10,517
+14% +$947K 0.04% 418
2024
Q3 		$6.38M Sell
76,117
-18,070
-19% -$1.38M 0.04% 511
2024
Q2 		$6.05M Buy
94,187
+33,007
+54% +$2.2M 0.03% 526
2024
Q1 		$4.48M Buy
61,180
+6,316
+12% +$486K 0.03% 563
2023
Q4 		$4.44M Buy
54,864
+7,007
+15% +$545K 0.04% 498
2023
Q3 		$3.59M Buy
47,857
+8,417
+21% +$647K 0.04% 490
2023
Q2 		$3.04M Sell
39,440
-2,798
-7% -$223K 0.03% 540
2023
Q1 		$3.5M Sell
42,238
-41,261
-49% -$3.42M 0.04% 459
2022
Q4 		$7.17M Buy
83,499
+9,338
+13% +$739K 0.06% 325
2022
Q3 		$4.58M Buy
74,161
+6,585
+10% +$415K 0.05% 397
2022
Q2 		$4.18M Buy
67,576
+16,494
+32% +$1.02M 0.04% 406
2022
Q1 		$3.04M Sell
51,082
-24,530
-32% -$1.57M 0.03% 532
2021
Q4 		$5.49M Buy
75,612
+2,161
+3% +$149K 0.06% 340
2021
Q3 		$5.13M Buy
73,451
+18,542
+34% +$1.3M 0.05% 382
2021
Q2 		$3.78M Buy
54,909
+1,310
+2% +$87.5K 0.04% 438
2021
Q1 		$3.46M Buy
53,599
+1,460
+3% +$94.1K 0.04% 424
2020
Q4 		$2.95M Buy
52,139
+7,770
+18% +$469K 0.03% 468
2020
Q3 		$2.81M Buy
+44,369
New +$3.08M 0.05% 347

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Kestra Advisory Services's GILD Position: Q2 2026 in Review

Kestra Advisory Services increased its Gilead Sciences (GILD) stake by 4.7% in Q2 2026, buying an estimated $604K and bringing the position to 102,648 shares worth $13M. The position accounts for 0.04% of the portfolio, ranked #438.

Kestra Advisory Services first reported a position in GILD in Q3 2020 and has held it in 24 quarters since. The position peaked at $13.7M in Q1 2026. 2,281 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Kestra Advisory Services held 102,648 shares of Gilead Sciences worth $13M as of Q2 2026.
  • Kestra Advisory Services bought 4,587 Gilead Sciences shares in Q2 2026, an estimated $604K.
  • Gilead Sciences made up 0.04% of Kestra Advisory Services's portfolio in Q2 2026, its #438 holding.
  • Kestra Advisory Services first reported a position in Gilead Sciences in Q3 2020 and has held it in 24 quarters since.
  • Kestra Advisory Services's Gilead Sciences position peaked at $13.7M in Q1 2026.
  • 2,281 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.